Why Is GLOBE LIFE INC (GL) Stock Down Today?

Globe Life Inc. stock fell 7.89% to $169.49 in morning trading on Tuesday. The decline followed the release of the insurer's second-quarter earnings report and related filings, which included a gap down of 7.5% from the prior close. Despite reporting a rise in net income, the stock reacted negatively to mixed results and downward guidance adjustments.

What Happened

Globe Life Inc. reported second-quarter 2026 net income of $3.65 per diluted common share, up from $3.05 per share in the same period of the prior year. The company filed a Form 8-K on July 22 disclosing its results of operations and financial condition. However, adjusted earnings of $3.61 per share missed estimates of $3.68, while revenue of $1.6 billion beat expectations of $1.589 billion. The company also raised its full-year adjusted EPS guidance to a range of $15.55 to $15.95 per share, just above the $15.64 consensus estimate. Despite these updates, the stock opened with a significant gap down and remained in negative territory throughout the session.

Recent insider transactions show multiple executives and directors sold shares in June, including EVP and Chief Administrative Officer Skarjune Dolores, Director Cheryl Alston, and EVP and Chief Talent Officer Rebecca Zorn. These sales totaled $16.7 million in the last 90 days. A Republican senator, Alan Armstrong, disclosed a purchase of $1,001 to $15,000 in March. Retail traders on social media platforms have not shown significant chatter about the stock in the past 24 hours.

What The Data Shows

The stock opened at $170.18, a 7.5% gap down from the prior close of $184.00. It reached an intraday high of $175.47 at 9:30 AM ET and a low of $168.17 at the same time. Trading volume so far is 0.8 million shares, or 1.4 times the 3-month daily average. The stock is currently trading within its 52-week range of $120.05 to $191.55. With a market cap of $14.3 billion, a P/E ratio of 12.7, and a beta of 0.47, Globe Life is positioned as a relatively stable insurance stock. However, the recent insider selling and mixed earnings results have weighed on investor sentiment.

What To Watch

Globe Life has no scheduled earnings date in the near term but will likely remain under close watch for analyst reactions and coverage breadth. Analysts at TD Cowen and JPMorgan have maintained positive outlooks, with updated price targets of $225 and $201 respectively.